Clinical Trials · NCT06445075
Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Scholar Rock, Inc.
- Enrollment
- 102
- Start date
- May 2024
- Locations
- 7 sites, United States
- Primary endpoint
- Change from Baseline in total Lean Body Mass (kg) at 24 weeks